A new research paper was published in Volume 17 of Oncotarget on May 20, 2026, titled "Microenvironmental CTHRC1 has a ...
2don MSN
Colorectal cancer has a backup plan, and it begins when mature gut cells regain stem-like traits
In a recent study, Stevens researchers have shown how colorectal cancers can evolve from mature intestinal cells that revert ...
A new research paper was published in Volume 17 of Oncotarget on May 20, 2026, titled “Microenvironmental CTHRC1 has a ...
Tumor deposits are a significant prognostic factor in colorectal cancer, yet underutilized in N-staging. Ten novel models incorporating tumor deposits showed improved prognostic performance over the ...
An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...
For the first time, a blood test has been added to the list of the American Cancer Society’s recommended screenings for ...
An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...
Circulating tumor DNA to guide rechallenge with cetuximab plus irinotecan in Chinese RAS/BRAF wild type metastatic colorectal cancer: A phase II trial. Survival outcomes of first-line anti-EGFR ...
Personalis, Inc. (Nasdaq: PSNL) today announced clinical data from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting establishing the clinical importance of ultrasensitive MRD ...
Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis in patients with colon and rectal cancer. It may also ...
Cancerguard screens for 50 types of cancer with one blood test. Doctors explain the accuracy, benefits and limits of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results